U.S. Congresswoman Rosa DeLauro (CT-03) visited Arvinas, a New Haven pharmaceutical development company, February 1 to highlight the increase in funding for the National Institutes of Health in the 2016 federal budget.

At the event, DeLauro was joined by Dr. Craig Crews, Founder and Chief Scientific Advisor of Arvinas; Dr. Roy S. Herbst, Chief of Medical Oncology at Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven; Dr. Patricia LoRusso, Professor of Medicine (Medical Oncology) and Associate Director of Innovative Medicine at Yale Cancer Center; and Dr. Susan Froshauer, President/CEO of CURE.